Falcon (Edison Scientific) deep research report: Pfkfb4 (rat, UniProt P25114) functional annotation
-
Falcon confirms the gene identity (UniProt P25114, rat Pfkfb4) as the testis-type member of the bifunctional PFKFB1-4 family, with two independent catalytic domains.
"PFKFB enzymes are **bifunctional homodimers** with **two independent catalytic domains**: an **N-terminal kinase (PFK-2)** domain that synthesizes F-2,6-BP and a **C-terminal phosphatase (FBPase-2)** domain that degrades F-2,6-BP."
-
Falcon corroborates the two opposing catalytic activities and their EC numbers, consistent with the existing kinase and phosphatase annotations.
"Fructose-2,6-bisphosphate is produced from fructose-6-phosphate by **6-phosphofructo-2-kinase (PFK-2; EC 2.7.1.105)** and hydrolyzed by **fructose-2,6-bisphosphatase (FBPase-2; EC 3.1.3.46)**; in mammals these opposing activities occur within the same bifunctional PFKFB enzymes."
-
Falcon describes the metabolic role of fructose-2,6-bisphosphate as a potent allosteric regulator that activates PFK1 and inhibits fructose-1,6-bisphosphatase, supporting the glycolysis and gluconeogenesis process annotations as downstream regulatory context.
"At **submicromolar concentrations**, it stimulates glycolysis and inhibits gluconeogenesis by:"
-
Falcon supports the cytosolic localization annotation as the primary family-level evidence, noting nuclear staining is a human-cancer context not to be generalized to rat.
"**Cellular component:** primary evidence supports a **cytosolic** enzyme family location; nuclear staining has been observed in a human COAD context but should not be treated as canonical for rat without direct validation."
-
Falcon confirms the testis-enriched expression matching the UniProt testis-type isozyme identity.
"PFKFB4 is repeatedly described as being **mainly expressed in the testes** and as the **testis isoform** within the four PFKFB genes"
-
Falcon notes PFKFB4 has a kinase-biased activity ratio (recombinant human kinase ~4.3-fold greater than phosphatase), consistent with retaining both catalytic activities as core functions.
"Recombinant PFKFB4 kinase activity 4.3-fold greater than phosphatase activity"